PSA is the most common biomarker used in the screening and monitoring of prostate cancer. However, changes in PSA do not always reflect disease dynamics in every patient, and antihormonal agents may modulate its levels without significant antitumor effects. Changes in circulating tumor cells (CTC) h...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!